BioCentury
ARTICLE | Financial News

CStone raises $285M in Hong Kong IPO

February 25, 2019 5:32 AM UTC

CStone Pharmaceuticals Co. Ltd. (HKSE:2616) priced its IPO on the Hong Kong stock exchange early Monday, raising HK$2.2 billion (US$285 million).

The offering values CStone at HK$11.8 billion (US$1.5 billion). CStone sold 18.6 million shares to Hong Kong investors and 167.8 million shares to the international community at HK$12, near the middle of its proposed range of HK$11.10-HK$12.80 (see "CStone Could Get $1.5B Valuation in Hong Kong IPO")...